Literature DB >> 2892785

Identification of lymphoid cell lines bearing receptors for somatostatin.

H Nakamura1, T Koike, K Hiruma, T Sato, H Tomioka, S Yoshida.   

Abstract

The MT-2, derived from an adult T-cell leukaemia (ATL) cell, the Molt-4F, a human T-cell line, and the Isk, an EB virus-transformed B-cell line, were found to have high-affinity receptors for somatostatin, a cyclic tetradecapeptide that inhibits the release of substances such as growth hormone, TSH, glucagon, insulin, secretin, gastrin and cholecystokinin. The quantity of radioactivity bound varied linearly with the number of cells, and was displaced by non-radioactive somatostatin in a concentration-dependent manner. Specific binding of 125I-somatostatin was time- and temperature-dependent and at 22 degrees reached equilibrium within 120 min. Scatchard analysis demonstrated one class of specific-binding sites on MT-2 cells, Isk cells and Molt-4F cells that had respective densities and dissociation constants of 109 pM and 0.64 nM, 102 pM and 1.1 nM, and 5.8 pM and 0.22 nM.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2892785      PMCID: PMC1454144     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts.

Authors:  D G Payan; C A Hess; E J Goetzl
Journal:  Cell Immunol       Date:  1984-04-01       Impact factor: 4.868

2.  SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action.

Authors:  W Bauer; U Briner; W Doepfner; R Haller; R Huguenin; P Marbach; T J Petcher
Journal:  Life Sci       Date:  1982-09-13       Impact factor: 5.037

Review 3.  Noradrenergic and peptidergic innervation of lymphoid tissue.

Authors:  D L Felten; S Y Felten; S L Carlson; J A Olschowka; S Livnat
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

4.  A monoclonal antibody that detects a polymorphic determinant common to HLA-DR1 and 2.

Authors:  M Kasahara; K Ogasawara; H Ikeda; T Okuyama; N Ishikawa; T Takenouchi; A Wakisaka; Y Kikuchi; M Aizawa
Journal:  Tissue Antigens       Date:  1983-02

5.  Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells.

Authors:  I Miyoshi; I Kubonishi; S Yoshimoto; T Akagi; Y Ohtsuki; Y Shiraishi; K Nagata; Y Hinuma
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

6.  Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes.

Authors:  B F Haynes; M E Hemler; D L Mann; G S Eisenbarth; J Shelhamer; H S Mostowski; C A Thomas; J L Strominger; A S Fauci
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

7.  Somatostatin receptors on rat anterior pituitary membranes.

Authors:  A Enjalbert; L Tapia-Arancibia; M Rieutort; P Brazeau; C Kordon; J Epelbaum
Journal:  Endocrinology       Date:  1982-05       Impact factor: 4.736

8.  Characterization of human interleukin 2 receptor (Tac antigen) in normal and leukemic T cells: co-expression of normal and aberrant receptors on Hut-102 cells.

Authors:  Y Wano; T Uchiyama; K Fukui; M Maeda; H Uchino; J Yodoi
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

9.  Somatostatin has an antiproliferative effect on concanavalin A-activated rat thymocytes.

Authors:  R N Mascardo; R W Barton; P Sherline
Journal:  Clin Immunol Immunopathol       Date:  1984-10

10.  In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells.

Authors:  C A Ottaway
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

View more
  4 in total

1.  Somatostatin receptors on human lymphocytes and leukaemia cells.

Authors:  K Hiruma; T Koike; H Nakamura; T Sumida; T Maeda; H Tomioka; S Yoshida; T Fujita
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

2.  Indium-111 pentetreotide scintigraphy in malignant lymphomas.

Authors:  L Sarda; M Duet; J M Zini; B Berolatti; S Benelhadj; G Tobelem; O Mundler
Journal:  Eur J Nucl Med       Date:  1995-10

3.  Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype.

Authors:  M Levite
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

4.  Scintigraphic imaging of small-cell lung cancer with [111In]pentetreotide, a radiolabelled somatostatin analogue.

Authors:  K J O'Byrne; J T Ennis; P J Freyne; L J Clancy; J S Prichard; D N Carney
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.